|

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

RECRUITINGN/ASponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Actively Recruiting
PhaseN/A
SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Started2016-04-27
Est. completion2026-04-27
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

This randomized clinical trial studies how well high volume washing of the abdomen works in increasing survival after surgery in patients with pancreatic cancer that can be removed by surgery. High volume washings may remove free floating cancers present after surgery and help prolong survival in patients with pancreatic cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* The subject has a surgical indication for pancreatectomy (pancreaticoduodenectomy, distal pancreatectomy, total pancreatectomy) as determined by the treating physician/surgeon
* A diagnosis of pancreatic or other periampullary cancer is suspected preoperatively
* In the opinion of the surgeon, the subject has no medical contraindications to pancreatectomy
* Age ≥18 years of age.
* The subject is willing to consent to randomization of EAL-S vs. standard EAL-W vs. no extensive lavage. (SOC)

Exclusion Criteria:

* The subject does not have a surgical indication for pancreatectomy
* In the opinion of the surgeon, the subject has medical contraindications to pancreatectomy
* Age \< 18 years of age
* The subject is not willing to consent to EAL-S vs. EAL-W vs. no extensive lavage (SOC)
* Known benign or indolent disease, including benign pancreatic cystic tumors or pancreatic endocrine tumors) without possible risk of malignancy
* Other malignancy within five years, unless the probability of recurrence of the prior malignancy is \< 5% as determined by the principal investigator based on available information. Patient's curatively treated for squamous and basal cell carcinoma of the skin or patients with a history of malignant tumor in the past that have been disease free for at least five years are also eligible for this study.
* Evidence of metastatic disease preoperatively.

Conditions9

Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCancerCholangiocarcinomaDuodenal AdenocarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Intraductal Papillary Mucinous NeoplasmPeriampullary Adenocarcinoma

Locations2 sites

Ohio

1 site
Case Western Reserve University
Cleveland, Ohio, 44106
Jordan Winter, MD216-844-5777jordan.winter@UHhospitals.org

Pennsylvania

1 site
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
Harish Lavu, MD215-955-9402harish.lavu@jefferson.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.